SRPT FY 2011 Earnings — Sarepta Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

SRPTSarepta Therapeutics, Inc.

$2B

FY 2011 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$47M+59.7% YoY

Gross Profit

$11M23.5% margin

Operating Income

-$36M-76.5% margin

Net Income

-$2M-4.9% margin

EPS (Diluted)

$-0.11

Cash Flow

Operating Cash Flow

-$24M

Free Cash Flow

-$26M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$54M

Total Liabilities

$23M

Stockholders' Equity

$31M

Cash & Equivalents

$40M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$47M	$29M	+59.7%
Gross Profit	$11M	$2M	+463.9%
Operating Income	-$36M	-$21M	-71.6%
Net Income	-$2M	-$32M	+92.8%